Skip to main content

Effects of gamma-vinyl GABA (vigabatrin) on blood pressure and body weight of hypertensive and normotensive rats

Naunyn-Schmiedeberg's Archives of Pharmacology volume 345, pages 181–186 (1992)Cite this article

Summary

Inactivation of GABA was inhibited by γ-vinyl GABA (GVG) and the effects of the increased GABA level in the brain on blood pressure and body weight of spontaneously hypertensive rats (SHR) and normotensive rats (WKY) were investigated.

When started at the age of 8 weeks or 5 weeks, treatment of SHR and WKY with GVG (150 mg/kg, s.c.) for several weeks did not influence systolic blood pressure. In 1-week old SHR, treatment with GVG (up to 150 mg/kg, s.c.) abolished the rise in blood pressure until animals were 8 weeks old. Thereafter, arterial blood pressure started to increase but it remained distinctly lower than that in untreated animals. When started at the age of 1 week, treatment with GVG for 7 weeks did not influence arterial blood pressure in WKY. GVG delayed increase in body weight in SHR and WKY, irrespective of their age. GVG greatly increased GABA levels in the hypothalamus, frontal cortex, brainstem and rest of the brain in both WKY and SHR.

It is concluded that an increase in the GABA level in the brain leads to a delay in the development of hypertension in young SHR. Hence, development of genetic hypertension seems to be susceptible to activation of the GABAergic system in a very early critical phase only.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  • Abdul-Ghani AS, Coutinho-Netto J, Bradford HF (1980) The acting of γ-vinyl-GABA and γ-acetylenic-GABA on the resting and stimulated release of GABA in vivo. Brain Res 191:471–481

    Google Scholar 

  • Antonaccio MJ, Taylor DG (1977) Involvement of central GABA receptors in the regulation of blood pressure and heart rate of anaesthetized cats. Eur J Pharmacol 46:283–287

    Google Scholar 

  • Bedwani JS, Mehta A (1987) Effects of the γ-aminobutyrate transaminase inhibitors gabaculine and γ-vinyl GABA on γ-aminobutyric acid release from slices of rat cerebral cortex. Neurochem Res. 12:49–52

    Google Scholar 

  • Bhargava KP, Bhattacharya SS, Srimal RC (1964) Central cardiovascular actions of γ-aminobutyric acid. Br J Pharmacol 23:383–390

    Google Scholar 

  • Biswas B, Carlsson A (1977) The effect of intracerebroventricularly administered GABA on brain monoamine metabolism. Naunyn-Schmiedeberg's Arch Pharmacol 299:41–46

    Google Scholar 

  • Bousquest P, Feldman J, Bloch R, Schwartz J (1984) Pharmacological analysis of the central cardiovascular effects of four GABA analogues. Naunyn-Schmiedeberg's Arch Pharmacol 325: 291–297

    Google Scholar 

  • Catelli JM, Giakas WJ, Sved AF (1987) GABAergic mechanisms in nucleus tractus solitarius alter blood pressure and vasopressin release. Brain Res 403:279–289

    Google Scholar 

  • Cooper BR, Howard JL, White HL, Soroko F, Ingold K, Maxwell RA (1980) Anorexic effects of ethanolamine-0-sulfate and muscimol in the rat: evidence that GABA inhibits ingestive behavior. Life Sci 26:1997–2002

    Google Scholar 

  • Elliott KAC, Hobbiger F (1959) γ-Aminobutyric-acid: circulatory and respiratory effects in different species; re-investigation of the anti-strychnine action in mice. J Physiol (Lond) 146:70–84

    Google Scholar 

  • Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13:655–669

    Google Scholar 

  • Gram L, Larsson OM, Johnsen, AH, Schousboe A (1988) Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultures neurons. Epilepsy Res 2:87–95

    Google Scholar 

  • Grove J. Gardner CR, Richards MH (1982) Measurement of release of endogenous GABA and catabolites of [3H]GABA from synaptosomal preparations using ion-exchange chromatography. Neurochem Res 7:589–599

    Google Scholar 

  • Hambley JW, Johnston GAR, Shaw J (1984) Alterations in a hypothalamic GABA system in the spontaneously hypertensive rat. Neurochem Int 6:813–821

    Google Scholar 

  • Harrap SB, Van der Merwe WM, Griffin SA (1990) Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertention 16:603–614

    Google Scholar 

  • Huot S, Palfreyman MG (1982) Effects of γ-vinyl GABA on food intake of rats. Pharmacol Biochem Behav 17:99–106

    Google Scholar 

  • Jung MJ, Lippert B, Metcalf BW, Böhlen P, Schechter PJ (1977) γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 29:797–802

    Google Scholar 

  • Klausmair A, Philippu A (1989) Carotid occlusion increases the release of endogenous GABA in the nucleus of the solitary tract. Naunyn-Schmiedeberg's Arch Pharmacol 340:764–766

    Google Scholar 

  • Kubo T, Kihara M (1987) Evidence for the presence of GABAergic and glycine-like systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat. Neurosci Lett 74:331–336

    Google Scholar 

  • Lippert B, Metcalf BW, Jung MJ, Casara P (1977) 4-Amino-hex-5-enoic acid, a selective catalaytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur J Biochem 74:441–445

    Google Scholar 

  • Löscher W (1981) Relationship between drug-induced changes in seizure thresholds and the GABA content of brain and brain nerve endings. Naunyn-Schmiedeberg's Arch Pharmacol 317:131–134

    Google Scholar 

  • Löscher W (1982) Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action. Arch Int Pharmacodyn 257:32–58

    Google Scholar 

  • Neal MJ and Shah MA (1990) Development of tolerance to the effects of vigabatrin (γ-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina. Br J Pharmacol 100:324–328

    Google Scholar 

  • Okada Y, Nitsch-Hassler C, Kim JS, Bak IJ, Hassler R (1971) Role of γ-aminobutyric acid (GABA) in the extrapyramidal motor system. I. Regional distribution of GABA in rabbit, rat, guinea pig and baboon CNS. Exp Brain Res 13:514–518

    Google Scholar 

  • Olgiati VR, Netti C, Guidobond F (1980) The central GABAergic system and control of food intake under different experimental conditions. Psychopharmacology 68:163–167

    Google Scholar 

  • Persson B, Henning M (1980) Effect of GABA analogues on blood pressure and central GABA metabolism in the rat. Acta Pharmacol Toxicol 47:135–143

    Google Scholar 

  • Philippu A, Przuntek H, Roensberg W (1973) Superfusion of the hypothalamus with γ-aminobutyric acid: effect on release of noradrenaline and blood pressure. Naunyn-Schmiedeberg's Arch Pharmacol 276:103–118

    Google Scholar 

  • Philippu A (1988) Regulation of blood pressure by central neurotransmitters and neuropeptides. Rev Physiol Biochem Pharmacol 111:1–115

    Google Scholar 

  • Schechter PJ, Tranier Y, Jung MJ, Böhlen P (1977) Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45:319–328

    Google Scholar 

  • Sved AF, Sved JC (1990) Endogenous GABA acts on GABAB recpetors in nucleus tractus solitarius to increase blood pressure. Brain Res 526:235–240

    Google Scholar 

  • Tuomisto L, Yamatodani A, Died H, Waldmann U, Philippu A (1983) In vivo release of endogenous catecholamines, histamine and GABA in the hypothalamus of Wistar Kyoto and spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 323:183–187

    Google Scholar 

  • Winne D (1965) Zur Auswertung von Versuchsergebnissen: Die Prüfung, ob Kurven sich in ihrem Verlauf unterscheiden. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 250:383–396

    Google Scholar 

  • Yang CP, Lin MT (1983) Amino acids injected into the cerebroventricular system induce an enhancement of reflex bradycardia in the rat. Neuropharmacology 22:1190–1193

    Google Scholar 

Download references

Author information

Affiliations

  1. Institut für Pharmakodynamik und Toxikologie der Universität Innsbruck, Peter-Mayr-Strasse 1, A-6020, Innsbruck, Austria

    N. Singewald, A. Pfitscher & A. Philippu

Authors
  1. N. Singewald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Pfitscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Philippu
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Send offprint requests to N. Singewald at the above address

This work was supported by the Fonds zur Förderung der wissenschaftlichen Forschung

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Singewald, N., Pfitscher, A. & Philippu, A. Effects of gamma-vinyl GABA (vigabatrin) on blood pressure and body weight of hypertensive and normotensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 345, 181–186 (1992). https://doi.org/10.1007/BF00165734

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165734

Key words

  • SHR
  • γ-vinyl GABA
  • Vigabatrin
  • Blood pressure
  • Body weight
  • Genetic hypertension
  • Critical phase